Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141635 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141636 |
| CAS No | NA |
| Mol.F. | C26H39N3O6 |
| Mol.Wt. | 489.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141637 |
| CAS No | NA |
| Mol.F. | C58H69F6N5O7 |
| Mol.Wt. | 1062.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141638 |
| CAS No | NA |
| Mol.F. | C29H34F3N3O4 |
| Mol.Wt. | 545.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141639 |
| CAS No | NA |
| Mol.F. | C12H19N3O3S |
| Mol.Wt. | 285.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141640 |
| CAS No | NA |
| Mol.F. | C12H17N3O4S |
| Mol.Wt. | 299.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141641 |
| CAS No | NA |
| Mol.F. | C16H20N2O3 |
| Mol.Wt. | 288.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141642 |
| CAS No | NA |
| Mol.F. | C12H19N5O4S |
| Mol.Wt. | 329.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141643 |
| CAS No | NA |
| Mol.F. | C22H16N8O2 |
| Mol.Wt. | 424.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141644 |
| CAS No | NA |
| Mol.F. | C21H20FN9O3 |
| Mol.Wt. | 465.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141645 |
| CAS No | NA |
| Mol.F. | C19H16FN9O3 |
| Mol.Wt. | 437.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141646 |
| CAS No | NA |
| Mol.F. | C44H70N2O14 |
| Mol.Wt. | 851.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141647 |
| CAS No | NA |
| Mol.F. | C22H20N4O6 |
| Mol.Wt. | 436.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141648 |
| CAS No | NA |
| Mol.F. | C20H17N3O5 |
| Mol.Wt. | 379.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141649 |
| CAS No | NA |
| Mol.F. | C22H19ClN4O5 |
| Mol.Wt. | 454.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141650 |
| CAS No | NA |
| Mol.F. | C21H18N4O5 |
| Mol.Wt. | 406.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |